Futile treatment, disclosure and medical errors

Medical ethics rests on four pillars: beneficence (acting in the patient's best interest), non-maleficence (avoiding harm), autonomy (respecting patient choices), and justice (fair allocation of resources). When these principles conflict, clinicians must navigate complex decisions about what treatment to offer, what to disclose, and how to respond when things go wrong.

Futile treatment refers to interventions that cannot achieve their intended physiological goal or offer no meaningful benefit to the patient. The term is often used interchangeably with non-beneficial treatment, though subtle distinctions exist. Futility is typically judged against physiological criteria—for example, a treatment that cannot restore organ function or alter the disease trajectory. Non-beneficial treatment is a broader concept that includes interventions that might work physiologically but fail to improve the patient's quality of life, survival, or overall well-being.

Disclosure in medicine encompasses two distinct obligations. First, informed consent requires that patients receive adequate information about proposed treatments, including risks, benefits, and alternatives, before agreeing to proceed. Second, when medical errors occur, clinicians have an ethical—and often legal—duty to disclose the error to the patient or their family. This includes explaining what happened, why it happened, and what steps will be taken to mitigate harm.

Medical errors are preventable adverse events caused by healthcare management rather than the underlying disease process. They range from medication dosing mistakes to surgical errors to diagnostic delays. The ethical response to errors involves transparency, apology, and a commitment to preventing recurrence.

The ethical framework for these issues is not merely theoretical. Clinicians face real-world pressures: family demands for aggressive treatment, fear of litigation, and emotional distress after errors. Understanding the principles helps clinicians respond thoughtfully rather than reactively.

The concept of futility has evolved from a simple physiological judgment to a more nuanced ethical analysis. A treatment is physiologically futile when it cannot achieve its intended biological effect—for example, cardiopulmonary resuscitation in a patient with massive, irreversible organ failure. A treatment is non-beneficial when it might achieve a physiological effect but offers no meaningful benefit to the patient—for example, continuing mechanical ventilation in a patient with irreversible coma and no prospect of recovery.

The ethical analysis of futility involves several key considerations:

• Physiological criteria: Can the treatment achieve its intended effect? This is a factual question, often answered by evidence and clinical judgment.
• Quality of life: Even if the treatment works, does it produce a life the patient would consider worth living? This involves the patient's values and preferences.
• Burden vs. benefit: Does the treatment's burden (pain, suffering, resource use) outweigh its potential benefit? This requires weighing subjective and objective factors.
• Resource allocation: In settings of scarcity, providing futile treatment to one patient may deprive others of beneficial treatment. This raises justice concerns.

When clinicians and families disagree about futility, several approaches can help:

1. Communication: Engage in honest, empathetic dialogue about the patient's prognosis, values, and goals. Avoid technical jargon.
2. Ethics consultation: Involve the hospital ethics committee to facilitate discussion and mediate disputes.
3. Second opinions: Offer the family an independent assessment from another clinician.
4. Time-limited trials: Agree to continue treatment for a defined period, with clear criteria for reassessment.
5. Transfer of care: If the family remains dissatisfied, offer to transfer the patient to another institution willing to provide the requested treatment.

The treatment-risk paradox, in which subjects at a decreased risk of death are more likely to receive treatment, has been previously observed and discussed in the context of pharmacological treatment of patients with cardiovascular disease^[1]. This paradox highlights a broader issue: clinicians often provide aggressive treatment to patients who are least likely to benefit, while withholding it from those who might benefit most. In the context of futility, this paradox underscores the importance of evidence-based decision-making rather than reflexive treatment.

Disclosure of medical errors follows a similar ethical logic. When an error occurs, the clinician must weigh the duty of transparency against fears of litigation or reputational damage. The ethical obligation is clear: patients have a right to know about errors that affect their care. Disclosure should include:

• What happened, in clear, non-technical language
• Why it happened, to the extent known
• What consequences the error may have for the patient
• What steps are being taken to address the harm and prevent recurrence
• A sincere apology, without admitting legal liability

The ethical response to errors also involves systemic analysis. Most errors result from system failures rather than individual incompetence. Reporting errors, participating in root cause analysis, and implementing safety improvements are part of the professional obligation to prevent future harm.

In summary, the ethical management of futility, disclosure, and errors requires a commitment to honesty, empathy, and evidence-based practice. Clinicians must balance respect for patient autonomy with professional judgment about what constitutes beneficial treatment. When errors occur, transparency and accountability are not optional—they are core professional duties.

When a patient asks for an alternative therapy, the clinician must balance respect for autonomy with professional responsibility to provide care that is supported by robust evidence. The first step is to explore the patient’s motivations—cultural beliefs, previous experiences, or information from non‑medical sources—and to clarify what the patient hopes to achieve. Open, non‑judgemental dialogue helps to identify any misconceptions about the proposed therapy’s efficacy or safety.

1. Identify the level of evidence – Determine whether the therapy has been evaluated in randomised controlled trials (RCTs) or high‑quality observational studies.
2. Quantify the effect – If data exist, look for absolute risk reductions and number‑needed‑to‑treat (NNT) figures, as these are most useful for shared decision‑making.
3. Consider harms – Evaluate reported adverse events, drug‑drug interactions, and any potential to delay proven treatment.

If the therapy lacks credible evidence, clinicians should explain that the absence of reliable data means the benefit cannot be quantified and the risk may be unknown. Emphasise that the standard of care is based on treatments that have demonstrated a clinically meaningful effect in well‑designed studies.

• Use plain language – Replace statistical jargon with concrete statements (e.g., “We do not have data showing this improves survival”).
• Provide context – Compare the unproven therapy with the proven alternative, highlighting known outcomes such as mortality or functional recovery rates.
• Document the discussion – Record the patient’s request, the information provided, and the agreed plan.

If the patient persists, consider the following steps:

Mrs. A, a 68‑year‑old with newly diagnosed atrial fibrillation, asks to use a herbal supplement instead of anticoagulation. The clinician explains that large RCTs have shown anticoagulants reduce stroke risk by about 60 % (relative risk reduction) and that the absolute risk reduction translates to an NNT of 30 over one year. No robust data exist for the herbal product, and it may increase bleeding risk. After discussion, Mrs. A agrees to start anticoagulation while continuing the supplement, with monitoring for interactions.

• Autonomy – Respect the patient’s right to make informed choices, but ensure those choices are truly informed.
• Beneficence – Recommend treatments that have demonstrated benefit.
• Non‑maleficence – Avoid causing harm by endorsing unproven therapies that could delay effective care.
• Justice – Allocate resources to interventions with proven efficacy rather than unverified alternatives.

By grounding the conversation in the best available evidence, clinicians can honour patient preferences while upholding professional standards and safeguarding patient outcomes.

Full disclosure in medicine means telling a patient (or their family) the complete truth about their diagnosis, prognosis, and any errors that occurred during their care. Breaking bad news is the skilled delivery of this information in a way that is honest, compassionate, and tailored to the patient’s ability to understand and cope. The ethical duty to disclose arises from respect for patient autonomy and the principle of truthfulness—patients cannot make informed decisions about treatment if they are denied relevant facts.

When breaking bad news, the clinician should first prepare by reviewing the clinical facts and anticipating emotional reactions. The setting matters: a quiet, private room, with adequate time and no interruptions. The clinician should begin by finding out what the patient already knows and how much they wish to know. This is not a one-way announcement but a dialogue. The information should be given in small chunks, using plain language, and checked for understanding at each step. Silence and tears are acceptable; the clinician should not rush to fill them with more words.

A key part of full disclosure is acknowledging uncertainty. Prognostic estimates are rarely certain, and patients deserve to know the range of possibilities. For example, if a treatment has a 5-year survival rate of 60%, the patient should be told that this means 60 out of 100 similar patients are alive at 5 years, but that individual outcomes vary. This honesty builds trust, even when the news is grim.

Disclosure also extends to medical errors. If a patient has been harmed by an error, the clinician must explain what happened, why it happened, and what will be done to prevent recurrence. This is not merely a legal obligation but a moral one. Apologising does not admit legal liability; it acknowledges the patient’s suffering. The Victorian health system, for example, tracks open disclosure status through the VHIMS Minimum Data Set, and analyses are stratified by incident severity rating, healthcare service, and incident type to identify patterns in disclosure practice. This shows that disclosure is treated as a measurable, auditable component of care, not an optional courtesy. ^[3]

Special populations require adapted approaches. In children, disclosure must be developmentally appropriate—a 6-year-old needs different words than a 16-year-old. In pregnancy, bad news often involves the fetus, and both parents may need to be present. In older adults, cognitive impairment may require repeated explanations and involvement of carers. In low-resource settings, where treatments may be unavailable, disclosure must include honest discussion of what can and cannot be done, without offering false hope.

Full disclosure is not a single event but a process. Patients may need to hear the news several times before it sinks in. The clinician should offer written information, involve specialist nurses or counsellors, and arrange follow-up. In the case of errors, the disclosure should be documented, and the patient should be offered support, including access to an independent advocate if they wish.

Finally, the clinician must care for themselves. Breaking bad news repeatedly is emotionally draining. Debriefing with colleagues, seeking supervision, and acknowledging one’s own limits are part of professional practice. A clinician who is burnt out cannot disclose well.

Duty of candour is the professional and legal obligation on healthcare organisations to be open and honest with patients when something goes wrong with their care. It requires clinicians and organisations to acknowledge adverse events, apologise, and explain what happened and what will be done to prevent recurrence. The concept has deep roots in professional ethics, but its formalisation as a legal duty is relatively recent.

The Statutory Duty of Candour was first introduced in the UK National Health Service in 2014, in direct response to major inquiries into failures of openness and adverse safety events. This marked an important shift: candour moved from being solely a professional and ethical responsibility toward a formal legal requirement for healthcare organisations. Since then, similar frameworks have been adopted internationally, with varying thresholds for inclusion and mechanisms for enforcement. ^[4]

The SDC legislation requires three core elements after an adverse event causing harm:

• Notification – the organisation must inform the patient that an adverse event has occurred
• Apology – a sincere expression of regret must be offered
• Explanation – the organisation must explain what actions are being taken to prevent recurrence

Evidence from early implementation in Victoria, Australia, shows that candour is experienced by patients not as a single disclosure event, but as an ongoing process that shapes trust after harm. When communication was sincere, empathetic, and followed by meaningful action, candour supported accountability and trust repair. When it was experienced as procedural or defensive, it often increased distress and undermined confidence in healthcare organisations. ^[4]

The practical impact of poorly enacted candour is measurable. Among patients who attended a post-incident meeting, over half (55%) reported dissatisfaction, and 65% rated the timeliness of staff communication as inadequate or uncertain. These figures highlight that the manner and speed of disclosure matter as much as the fact of disclosure itself. ^[4]

From a restorative justice perspective, patients expect candour to involve more than apology; they want accountability, learning, and visible system improvement. Therefore, SDC processes require demonstrable action to prevent recurrence, which may extend well beyond the timeframe of the formal disclosure process. Structured post-incident support can assist recovery for both patients and healthcare workers, reinforcing the relational and bidirectional nature of trust repair after harm. ^[4]

There are also risks when candour is poorly enacted. The emotional labour required of patients and families, coupled with the administrative complexity of the SDC process, left some participants feeling further disempowered rather than supported. These experiences highlight the risk of re-traumatisation when candour is poorly enacted or insufficiently supported. When emotional labour is shifted onto patients and families, and power imbalances remain unacknowledged, candour may move from a mechanism intended to support trust and healing to one that inadvertently compounds harm and distress. ^[4]

In summary, duty of candour is a legal obligation that, when enacted well, supports trust, learning, and accountability. When enacted poorly, it can compound harm. The evidence from early implementation suggests that sincerity, timeliness, and meaningful follow-up action are the determinants of whether candour heals or harms.

Medical errors are an unavoidable part of clinical practice, and how you respond to them shapes both patient trust and your own professional integrity. When an error causes harm, the instinct may be to minimise, deflect, or remain silent—but this is neither ethically nor legally sound. The core principle is transparency: patients have a right to know what happened, why it happened, and what will be done to prevent recurrence.

A formal apology should be made separately, not just because the SDC says to apologise. This means the apology must be genuine and delivered as a distinct act, not buried within a longer explanation or given reluctantly because a guideline demands it. The SDC (presumably a standards or disciplinary code) may require an apology, but the ethical weight comes from the sincerity behind it. ^[4]

When disclosing an error, consider the following practical steps:

• Act promptly – Delaying disclosure compounds the harm and erodes trust.
• Be honest and complete – Explain what happened in plain language, avoiding jargon or defensive framing.
• Take responsibility – Do not blame colleagues, systems, or the patient, even if contributing factors exist.
• Offer a formal apology – As noted, this should be a separate, deliberate act, not a passing remark.
• Document the conversation – Record what was disclosed, to whom, and when, in the patient's notes.

The emotional burden on the clinician is real. You may feel shame, fear of litigation, or self-doubt. These feelings are normal, but they must not drive you to conceal. Seek support from colleagues, a mentor, or a formal peer-support programme. Remember that the patient is the primary victim; you are the "second victim," and your wellbeing matters too—but not at the expense of honesty.

In summary, the ethical response to a medical error is transparent disclosure followed by a sincere, separate apology. This is not merely a box-ticking exercise; it is a fundamental respect for the patient's autonomy and dignity. The SDC may mandate the apology, but your character should make it voluntary.

Reporting in healthcare ethics refers to the formal processes by which clinicians disclose adverse events, errors, and near misses to patients, families, and relevant authorities. The most structured framework in this area is Supported Disclosure and Candour (SDC), a systematic approach to open disclosure that has been implemented in Victorian health services in Australia. SDC is not merely a legal obligation but a moral and relational practice that aims to repair trust after harm has occurred.

The foundation of effective reporting is that patients and families must first know that the process exists. Research participants have consistently noted that awareness of SDC is extremely low, even among those with excellent health system knowledge: "Patients and families need to know the SDC exists. This is the first I've heard of it and my knowledge of the health system is very good". This highlights a critical gap—disclosure cannot occur if patients do not know they are entitled to it. The same participants emphasised that the process should be explained proactively: "It gives you comfort knowing the process is there. But they should explain it upfront, before anything goes wrong". This suggests that reporting should not be reactive only; it should be part of routine care conversations. ^[4]

The practical mechanics of reporting involve several steps. When an adverse event occurs, the clinician must first recognise that a reportable event has taken place. This requires a shared understanding of what constitutes an adverse event, a requirement for disclosure, and specifically for SDC. The challenge here is that patients and health professionals may have different thresholds for what counts as harm. For example, in the context of perfusion deficits, researchers observed a significantly lower rate of no-reflow (3%) when they used a considerably higher threshold for assessing perfusion deficit (≥40% of regional cerebral blood flow reduction). This illustrates that the definition of an "event" can vary dramatically depending on the criteria applied, and clinicians must be explicit about their thresholds. ^{[2] [3]}

Once an event is identified, the reporting process typically follows a structured pathway. The clinician or institution must decide whether the event meets the criteria for SDC, which includes whether harm occurred, whether it was preventable, and whether the patient or family is aware of the event. The disclosure itself must be conducted in person, using clear and accessible language, and must include an apology, an explanation of what happened, and a plan for ongoing care and support.

The final step in reporting is documentation and follow-up. This is not merely administrative; it ensures that the disclosure is part of the patient's record and that any promised support is delivered. Participants in SDC research noted that "there was no offer of practical support, such as housecleaning, meal vouchers. An apology is nice, but what is needed is practical support". This underscores that reporting must go beyond words—it must include tangible actions that address the patient's real-world needs. ^[4]

Several recurring pitfalls undermine effective reporting and disclosure. The first is low awareness and activation thresholds. Many patients do not know SDC exists, and even when they do, they may not know how to initiate it. This is compounded by the use of "legalistic language" in disclosure documents, which creates structural barriers that limit equitable access to SDC before it is initiated. When patients encounter legal terminology, they may feel intimidated or confused, and may not understand their rights or the process itself. ^[4]

The second pitfall is framing candour as a legal or procedural requirement rather than a moral one. Research has shown that "the combination of legal terminology and limited public information may create a perception that SDC is primarily a legal or procedural requirement". When this happens, the disclosure feels transactional rather than genuine. Patients are positioned as "passive recipients, rather than active participants in safety and accountability processes". This erodes the very trust that disclosure is meant to restore. The solution, as participants emphasised, is that candour "must be communicated in language that is clear, accessible, and aligned with the needs of those it is intended to support". ^[4]

A third pitfall is insincerity in apology. A superficial or scripted apology can do more harm than no apology at all. Participants described how apology sincerity, emotional labour, and power dynamics shape whether candour repairs or further erodes trust. One participant captured this powerfully: "How important it is just to say sorry… It's validating and you feel you can trust a little bit more, even if they made a mistake". The key word here is "validating"—the apology must acknowledge the patient's experience of harm, not just the clinical error. If the apology is defensive or minimising, it will be perceived as insincere. ^[4]

A fourth pitfall is delaying disclosure. Participants noted that honesty must come early: "Even when people make mistakes, if people have just been honest at the start and taken accountability for it, then it wouldn't have caused the harm it caused". Delay is often driven by fear of litigation or by uncertainty about the facts. However, waiting to disclose can compound the harm, as patients may feel that the institution is hiding something. Early honesty, even when the full picture is not yet clear, is almost always better than delayed disclosure. ^[4]

A fifth pitfall is neglecting practical support. As noted above, an apology without practical assistance is often seen as hollow. Patients may need help with housecleaning, meal vouchers, transport, or counselling. Failing to offer these supports signals that the institution cares more about its own reputation than about the patient's recovery. Practical support is not an optional extra; it is an integral part of meaningful disclosure.

Finally, there is the pitfall of inconsistent terminology and understanding. The term "consumer" is used in Victorian health policy to refer to people who use health services, including patients, carers, and family members, whereas "patient" is more prevalent in the UK and US. This may seem trivial, but it can cause confusion about who is entitled to disclosure and who should be involved in the conversation. Clinicians must be clear about the terminology they use and ensure that all parties share the same understanding. ^[4]

SDC and open disclosure are used in practice across a range of healthcare settings, but their implementation varies significantly. In Victoria, Australia, SDC has been formally introduced, and research is ongoing to evaluate its use and impacts internationally. The framework is applied in hospitals, community health services, and primary care, though the depth of implementation differs.

In practice, SDC is used when an adverse event has caused harm to a patient. This includes events such as medication errors, surgical complications, missed diagnoses, and hospital-acquired infections. The process is initiated by the clinician or by the patient/family, and it involves a structured meeting where the event is discussed openly. The meeting should include the patient, family members if appropriate, the clinician(s) involved, and a trained SDC facilitator.

The practical application of SDC is shaped by the six themes identified in research, which reflect a progression from how SDC is understood in principle to how it is experienced in practice. Themes 1 and 2 capture the tension between broad support for candour as a moral right and scepticism about its genuine enactment. In practice, this means that while patients and clinicians may agree in principle that disclosure is important, there is often doubt about whether it will actually happen in a meaningful way. Clinicians must be aware of this scepticism and work actively to overcome it through genuine, transparent communication.

Theme 3 identifies structural barriers that can limit equitable access to SDC before it is initiated, including low awareness, legalistic language, and activation thresholds. In practice, this means that some patients—particularly those from disadvantaged backgrounds or with lower health literacy—may never access SDC, even when they have experienced harm. Clinicians and health services must therefore work to lower these barriers by providing information in plain language, offering translation services, and proactively reaching out to patients who may not know their rights.

Themes 4 and 5 draw on accounts from consumers with lived experience of SDC, examining the relational quality of the encounter itself. In practice, this means that the success of SDC depends heavily on how the disclosure conversation is conducted. Key factors include the sincerity of the apology, the emotional labour required of the clinician, and the power dynamics between clinician and patient. A disclosure that is rushed, defensive, or dismissive will fail, regardless of how well the process is documented.

In practice, SDC is also used in conjunction with other quality improvement processes. When an adverse event is disclosed, the information is fed back into the health service's safety systems to prevent future harm. This dual purpose—disclosure to the patient and learning for the organisation—is a core strength of the SDC framework. However, it requires that the disclosure process be conducted with integrity, without defensiveness, and with a genuine commitment to improvement.

Finally, SDC is used in practice to address the emotional and practical needs of patients and families. As noted, practical support such as housecleaning and meal vouchers is often needed. In practice, this means that the SDC team must have access to resources to provide such support, and must be willing to offer it proactively. An apology alone is insufficient; it must be accompanied by tangible assistance that addresses the patient's real-world needs.